Skip to main content

Table 3 miRNA levels differing in CD patients and healthy controls. Bold type indicates the most significantly different miRNAs

From: In search for interplay between stool microRNAs, microbiota and short chain fatty acids in Crohn’s disease - a preliminary study

Statistics

Counts

Probe Name

Control

CD

Padjust

P-value

t-statistic

FC

Upper 95% CI

Lower 95% CI

SD

Control

Upper 95% CI

Lower 95% CI

SD

mean

2.27E-02

1.52E-04

−5.21

−4.94

467.18

170.93

192.70

319.05

100.07

31.49

61.92

65.78

hsa-miR-577

3.10E-02

6.53E-04

−3.97

−3.65

958.18

427.83

344.98

693.00

457.24

98.43

323.96

277.83

hsa-miR-379-5p

3.10E-02

6.61E-04

−4.03

−4.18

993.98

403.93

383.81

698.95

530.38

73.58

412.44

301.98

hsa-miR-642a-3p

3.10E-02

8.33E-04

−3.98

−5.10

3688.71

1227.90

1600.70

2458.30

925.97

227.70

630.45

576.83

hsa-miR-26b-5p

1.48E-01

4.97E-03

3.22

7.68

121.66

15.04

69.36

68.35

11,532.45

N/A

12,490.41

4615.49

hsa-miR-223-3p

3.06E-01

1.23E-02

−2.75

−3.09

957.20

182.63

503.83

569.91

396.00

79.03

286.19

237.52

hsa-miR-361-5p

3.94E-01

2.25E-02

2.53

3.26

69.14

28.49

26.44

48.81

2920.51

N/A

3303.39

1091.15

hsa-miR-142-3p

3.94E-01

2.26E-02

−2.46

−2.17

508.60

202.53

199.09

355.57

301.91

91.82

189.68

196.87

hsa-miR-194-5p

3.94E-01

2.57E-02

−2.41

−2.37

387.17

165.77

144.02

276.47

237.50

66.22

154.65

151.86

hsa-miR-202-3p

3.94E-01

3.44E-02

2.34

2.39

40.00

40.00

0.00

40.00

915.66

N/A

936.19

397.21

hsa-miR-16-5p

3.94E-01

3.79E-02

−2.22

−2.74

6467.88

1662.47

3125.80

4065.17

3449.42

1007.05

2205.17

2228.23

hsa-miR-155-5p

3.94E-01

3.85E-02

2.25

2.21

63.15

30.85

21.01

47.00

536.93

N/A

487.63

266.89

hsa-miR-23a-3p

3.94E-01

4.73E-02

−2.23

−1.54

107.06

48.42

38.14

77.74

58.32

35.97

20.18

47.14

hsa-miR-141-3p